Tick season is here: What WVU Medicine doctors say you need to know

Temperatures are rising across West Virginia, Kentucky and Ohio, and medical experts are cautioning safety around tick ...
The Weather Network

We regret to inform you that ticks are already out and about

March is national tick awareness month in Canada, and the timing couldn’t be better (or worse, depending on how you look at ...

Marshfield Clinic Research Institute kicks off third year of citizen tick collecting

Building on two years of citizen support, Marshfield Clinic Research Institute is once again asking Wisconsin residents to ...

Lyme disease vaccine shows 70 percent efficacy, Pfizer says

If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...
WWMT on MSN

Pfizer announces promising trial results for Lyme disease vaccine

An announcement from Pfizer means Lyme disease numbers could soon drop.

Pfizer Lyme vaccine shows more than 70% efficacy but misses key statistical goal

There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot due to a lack of demand.

Pfizer and Valneva's Lyme disease vaccine shows 70% efficacy in clinical trial

Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory ...

Pfizer says long-awaited Lyme vaccine was effective in study

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though ...

Pfizer Lyme vaccine shows 70% efficacy, misses trial goal

Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical ...

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed ‌more than 70% efficacy in a ...
WXYZ-TV Channel 7

Ask Dr. Nandi: What does it mean that Pfizer's Lyme vaccine showed strong protection but missed study goal?

In today’s Health Alert, Pfizer’s Lyme vaccine shows strong protection in a phase 3 clinical trial, but misses a key study ...

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...